1. A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma – the SKOPOS trial. (2nd December 2018) Authors: Lester, Jason F; Casbard, Angela C; Al-Taei, Saly; Harrop, Richard; Katona, Lajos; Attanoos, Richard L; Tabi, Zsuzsanna; Griffiths, Gareth O Journal: Oncoimmunology Issue: Volume 7:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study. Issue 1 (29th January 2019) Authors: Hatton, Matthew Q F; Lawless, Claire Anne; Faivre-Finn, Corinne; Landau, David; Lester, Jason F; Fenwick, John; Simões, Rita; McCartney, Elaine; Boyd, Kathleen Anne; Haswell, Tom; Shaw, Ann; Paul, James Journal: BMJ open Issue: Volume 9:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. Issue 5 (May 2022) Authors: Hussain, Syed A; Lester, Jason F; Jackson, Richard; Gornall, Matthew; Qureshi, Muneeb; Elliott, Anthony; Crabb, Simon J; Huddart, Robert A; Vasudev, Naveen; Birtle, Alison J; Worlding, Jane; James, Nicholas D; Parikh, Omi; Vilarino-Varela, Maria; Alonzi, Roberto; Linch, Mark D; Riaz, Irbaz B; Cat... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. Issue 11 (November 2021) Authors: Fennell, Dean A; Ewings, Sean; Ottensmeier, Christian; Califano, Raffaele; Hanna, Gerard G; Hill, Kayleigh; Danson, Sarah; Steele, Nicola; Nye, Mavis; Johnson, Lucy; Lord, Joanne; Middleton, Calley; Szlosarek, Peter; Chan, Sam; Gaba, Aarti; Darlison, Liz; Wells-Jordan, Peter; Richards, Cathy; Poi... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Issue 10162 (1st December 2018) Authors: Parker, Christopher C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Hoyle, Alex P; Ali, Adnan; Ritchie, Alastair W S; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P; Gillessen, Silke; Gilson, Clare; Jones, Robert J; Langley, Ruth E; Malik, Zafar I; Mason, Mal... Journal: Lancet Issue: Volume 392:Issue 10162(2018) Page Start: 2353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗